524703 — Sandu Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹493.00m
- IN₹471.25m
- IN₹671.92m
- 80
- 34
- 55
- 61
Annual cashflow statement for Sandu Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 16.8 | 23.2 | 22.2 | 20.7 | 21.6 |
| Depreciation | |||||
| Non-Cash Items | 0.658 | 1.03 | -0.388 | -1.73 | 0.273 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 52.9 | -20 | -24.7 | -17.2 | -19.1 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 75.9 | 9.49 | 2.21 | 7.6 | 9.48 |
| Capital Expenditures | -1.27 | -8.41 | -10.7 | -14.3 | -9.38 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -54.5 | -46.3 | 16.1 | 1.18 | 7.52 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -55.8 | -54.7 | 5.37 | -13.1 | -1.86 |
| Financing Cash Flow Items | 7.85 | -1.1 | -0.796 | -0.632 | -1.04 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 13 | 9.34 | 5.79 | -7.25 | -4.62 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 33.1 | -35.9 | 13.4 | -12.7 | 3 |